APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Apyx Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.42−0.13 (-5.10%)
Close on Oct 19, 2026
- Market cap
- $106.12M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
58.5%
25M of 42M shares
Institutional holders
68
11 new, 10 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Daniel Mack | 4,112,705 | 9.99% | 13G (passive) amendment | Dec 31, 2025 |
| Nantahala Capital Management, LLC | 3,493,235 | 9.99% | 13G (passive) | Dec 31, 2024 |
| Royce & Associates LP | 3,274,064 | 7.81% | 13G (passive) amendment | Jun 30, 2026 |
| Constantinos Christofilis | 3,115,281 | 8.99% | 13G (passive) | Oct 31, 2024 |
| Stavros G. Vizirgianakis | 1,746,191 | 5.04% | 13D (active) amendment | May 7, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of APYX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 6,540,496 | 15.53% | $29.37M | +3,100,192 | 0.49% |
| Royce & Associates LP | 3,274,064 | 7.77% | $14.70M | +662,840 | 0.12% |
| Archon Capital Management LLC | 2,644,717 | 6.28% | $11.87M | −146,206 | 4.82% |
| Vanguard Capital Management LLC | 1,534,847 | 3.64% | $6.89M | −20,425 | 0.00% |
| Essex Investment Management Co LLC | 1,136,630 | 2.70% | $5.10M | +235,232 | 0.67% |
| AIGH Capital Management LLC | 1,128,343 | 2.68% | $5.07M | +23,373 | 0.32% |
| Silverberg Bernstein Capital Management LLC | 1,039,641 | 2.47% | $4.67M | −1,429 | 1.79% |
| Commonwealth Equity Services, LLC | 649,061 | 1.54% | $2.91M | – | 0.00% |
| Horizon Kinetics Asset Management LLC | 585,000 | 1.39% | $2.63M | −30,000 | 0.03% |
| BlackRock, Inc. | 560,986 | 1.33% | $2.52M | +33,238 | 0.00% |
| Renaissance Technologies LLC | 554,278 | 1.32% | $2.49M | +251,883 | 0.00% |
| Taylor Frigon Capital Management LLC | 413,602 | 0.98% | $1.86M | −957 | 0.87% |
| Geode Capital Management, LLC | 400,600 | 0.95% | $1.80M | +9,244 | 0.00% |
| Legato Capital Management LLC | 382,762 | 0.91% | $1.72M | +101,873 | 0.14% |
| Sei Investments Co | 281,029 | 0.67% | $1.26M | −317,226 | 0.00% |
| Huntleigh Advisors, Inc. | 263,231 | 0.62% | $1.18M | +17,311 | 0.17% |
| Millennium Management LLC | 242,663 | 0.58% | $1.09M | −19,395 | 0.00% |
| Marshall Wace, Llp | 236,466 | 0.56% | $1.06M | +174,630 | 0.00% |
| Vanguard Fiduciary Trust Co | 224,021 | 0.53% | $1.01M | +21,340 | 0.00% |
| Susquehanna International Group, Llp | 216,263 | 0.51% | $971.02K | −51,298 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 68 | 25M | 58.5% | 11 / 24 | 22 / 10 | 5M | 1M |
| Q1 2026 | 67 | 21M | 49.4% | 16 / 23 | 16 / 7 | 5M | 1M |
| Q4 2025 | 59 | 19M | 45.4% | 21 / 14 | 10 / 9 | 4M | 0M |
| Q3 2025 | 47 | 16M | 37.4% | 11 / 9 | 10 / 3 | 0M | 1M |
| Q2 2025 | 39 | 16M | 37.5% | 4 / 10 | 14 / 7 | 1M | 0M |
| Q1 2025 | 43 | 16M | 37.5% | 3 / 8 | 18 / 5 | 0M | 1M |
| Q4 2024 | 45 | 16M | 37.8% | 5 / 12 | 16 / 3 | 4M | 0M |
| Q3 2024 | 45 | 13M | 30.4% | 4 / 7 | 15 / 7 | 1M | 1M |
| Q2 2024 | 49 | 13M | 31.1% | 5 / 13 | 19 / 7 | 1M | 1M |
| Q1 2024 | 51 | 13M | 31.8% | 3 / 10 | 21 / 14 | 1M | 5M |
| Q4 2023 | 62 | 18M | 42.2% | 12 / 22 | 14 / 12 | 2M | 3M |
| Q3 2023 | 62 | 18M | 43.5% | 18 / 18 | 10 / 11 | 3M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of APYX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,095,524 | 2.60% | $4.92M | 0.00% | Jun 30, 2026 |
| Royce Small-Cap Opportunity Fund | 698,945 | 1.66% | $3.14M | 0.22% | Jun 30, 2026 |
| Royce Micro-Cap Fund | 586,780 | 1.39% | $2.63M | 0.62% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 399,651 | 0.95% | $1.79M | 0.00% | Jun 30, 2026 |
| 1290 Essex Small Cap Growth Fund | 276,178 | 0.66% | $1.13M | 0.97% | Jul 31, 2026 |
| Royce Capital Fund - Micro-Cap Portfolio | 215,125 | 0.51% | $965.91K | 0.69% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 179,731 | 0.43% | $718.03K | 0.00% | May 31, 2026 |
| Taylor Frigon Core Growth Fund | 128,436 | 0.30% | $513.10K | 1.42% | May 31, 2026 |
| iShares Micro-Cap ETF | 122,285 | 0.29% | $549.06K | 0.04% | Jun 30, 2026 |
| Siit Small Cap Ii Fund | 87,900 | 0.21% | $351.16K | 0.14% | May 31, 2026 |
| Fidelity Total Market Index Fund | 56,118 | 0.13% | $224.19K | 0.00% | May 31, 2026 |
| Ultra-Small Company Market Fund | 55,300 | 0.13% | $248.30K | 0.17% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 52,645 | 0.12% | $210.32K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 23,327 | 0.06% | $93.19K | 0.00% | May 31, 2026 |
| Venerable US Small Cap Fund | 22,033 | 0.05% | $98.93K | 0.06% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Charles D. Goodwin II | Chief Executive Officer, Director | 90,000 | 0.21% | Jun 15, 2026 |
| Shawn David Roman | Chief Operating Officer | 15,000 | 0.04% | Jun 17, 2026 |
| Moshe Citronowicz | Sr. V.P. of Operations | 493,504 | 1.17% | Jun 15, 2026 |
| Matthew C. Hill | Chief Financial Officer | 8,500 | 0.02% | Jun 15, 2026 |
| Lawrence Waldman | Director | 49,877 | 0.12% | Jul 2, 2026 |
| Minnie Baylor-Henry | Director | – | – | Jun 15, 2026 |
| Stavros G. Vizirgianakis | Director | 2,196,191 | 5.21% | Jun 15, 2026 |
| Wendy Lauren Levine | Director | – | – | Jun 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Lawrence Waldman Director | Jun 30, 2026 | Tax withholding | −5,024 | $4.49 | $22.56K | 12,314 |
| Lawrence Waldman Director | Jun 30, 2026 | Option exercise | +12,000 | $1.88 | $22.56K | 17,338 |
| Shawn David Roman Chief Operating Officer | Jun 15, 2026 | Option exercise | +15,000 | $3.23 | $48.45K | 15,000 |
| Shawn David Roman Chief Operating Officer | Jun 15, 2026 | Tax withholding | −10,533 | $4.60 | $48.45K | 16,467 |
| Stavros G. Vizirgianakis Director | Jun 11, 2026 | Award | +450,000 | – | – | 2,196,191 |
| Moshe Citronowicz Senior Vice President | Mar 15, 2026 | Option exercise | +37,000 | $1.80 | $66.60K | 493,504 |
| Shawn David Roman Chief Operating Officer | Jan 27, 2026 | Option exercise | +12,000 | $1.80 | $21.60K | 12,000 |
| Matthew C. Hill Chief Financial Officer | Aug 13, 2024 | Buy | +6,000 | $1.13 | $6.78K | 8,500 |
| Matthew C. Hill Chief Financial Officer | Aug 13, 2024 | Buy | +5,336 | $1.13 | $6.03K | 7,836 |
| Matthew C. Hill Chief Financial Officer | Dec 12, 2023 | Buy | +2,500 | $2.19 | $5.48K | 2,500 |
| Charles D. Goodwin II Chief Executive Officer, Director | Nov 14, 2023 | Buy | +50,000 | $1.57 | $78.50K | 90,000 |
| Lawrence Waldman Director | Jul 12, 2023 | Option exercise | +5,338 | $2.97 | $15.85K | 5,338 |
| Todd Hornsby Executive Vice President | Jun 26, 2023 | Option exercise | +15,000 | $1.77 | $26.55K | 15,000 |
| Todd Hornsby Executive Vice President | Jun 26, 2023 | Sale(10b5-1 plan) | −15,000 | $7.56 | $113.40K | 0 |
| Todd Hornsby Executive Vice President | Jun 26, 2023 | Sale(10b5-1 plan) | −15,000 | $7.56 | $113.40K | 40 |
| Todd Hornsby Executive Vice President | Jun 26, 2023 | Option exercise | +15,000 | $1.77 | $26.55K | 15,000 |
| Michael Geraghty Director | Jun 6, 2023 | Option exercise | +10,000 | $2.79 | $27.90K | 27,500 |
| Charles D. Goodwin II Chief Executive Officer, Director | Aug 29, 2022 | Buy | +2,000 | $5.93 | $11.86K | 30,250 |
| Charles D. Goodwin II Chief Executive Officer, Director | Aug 29, 2022 | Buy | +9,750 | $5.97 | $58.21K | 40,000 |
| Moshe Citronowicz Sr. V.P. of Operations | Jul 11, 2022 | Option exercise | +30,000 | $2.54 | $76.20K | 456,504 |
| Lawrence Waldman Director | Jul 11, 2022 | Option exercise | +24,000 | $2.54 | $60.96K | 37,563 |
| Michael Geraghty Director | Jul 6, 2022 | Option exercise | +4,000 | $2.54 | $10.16K | 17,500 |
| Andrew Makrides Director | Jul 5, 2022 | Tax withholding | −13,583 | $6.14 | $83.40K | 624,389 |
| Andrew Makrides Director | Jul 5, 2022 | Option exercise | +30,000 | $2.54 | $76.20K | 637,972 |
| Lawrence Waldman Director | May 19, 2022 | Option exercise | +8,000 | $2.79 | $22.32K | 13,563 |
| Michael Geraghty Director | May 11, 2022 | Option exercise | +6,000 | $2.79 | $16.74K | 13,500 |
| Craig A. Swandal Director | Mar 21, 2022 | Option exercise | +17,000 | $4.98 | $84.66K | 17,000 |
| Craig A. Swandal Director | Jan 7, 2022 | Option exercise | +7,173 | $9.42 | $67.57K | 60,173 |
| Lawrence Waldman Director | Mar 8, 2021 | Option exercise | +5,563 | $2.81 | $15.63K | 5,563 |
| Michael Geraghty Director | Mar 5, 2021 | Option exercise | +7,500 | $2.81 | $21.08K | 7,500 |
| Craig A. Swandal Director | Oct 7, 2020 | Option exercise | +7,084 | $7.28 | $51.57K | 17,000 |
| Charles D. Goodwin II Chief Executive Officer, Director | May 13, 2020 | Buy | +28,250 | $3.30 | $93.23K | 28,250 |
| Craig A. Swandal Director | Mar 4, 2020 | Option exercise | +9,916 | $7.28 | $72.19K | 17,000 |
| Craig A. Swandal Director | Oct 1, 2019 | Option exercise | +10,000 | $5.30 | $53.00K | 36,000 |
| Craig A. Swandal Director | Apr 4, 2019 | Exercise | +6,000 | $5.30 | $31.80K | 26,000 |
| Craig A. Swandal Director | Apr 4, 2019 | Option exercise | +2,000 | $2.37 | $4.74K | 20,000 |
| Craig A. Swandal Director | Jan 10, 2019 | Option exercise | +10,000 | $2.37 | $23.70K | 10,000 |
| Craig A. Swandal Director | Jan 10, 2019 | Option exercise | +8,000 | $5.30 | $42.40K | 18,000 |
| Andrew Makrides Director | Nov 8, 2018 | Gift | −2,000 | $6.84 | $13.68K | 605,972 |
| Andrew Makrides Director | Nov 8, 2018 | Gift | −2,000 | $6.84 | $13.68K | 607,972 |
| Andrew Makrides Director | Nov 8, 2018 | Gift | −2,000 | $6.84 | $13.68K | 609,972 |
| John J. McCarthy III Chief CommercializationOfficer | Aug 17, 2016 | Buy | +90,750 | $3.30 | $299.48K | 115,750 |
| John J. McCarthy III Chief Commercialization Office | Dec 22, 2015 | Buy | +25,000 | $1.98 | $49.50K | 25,000 |
| Moshe Citronowicz Sr. V.P. of Operations | Dec 21, 2015 | Buy | +20,000 | $1.84 | $36.80K | 426,504 |
| Robert Gershon Chief Executive Officer, Director | Dec 21, 2015 | Buy | +10,000 | $1.82 | $18.20K | 30,000 |
| Robert Gershon Chief Executive Officer, Director | Aug 14, 2015 | Buy | +20,000 | $2.39 | $47.80K | 20,000 |
| Point Partners Llc Great – | Mar 17, 2015 | Award | +480,000 | $2.50 | $1.20M | 480,000 |
| Andrew Makrides Director | Sep 19, 2014 | Option exercise | +25,000 | $2.13 | $53.25K | 624,213 |
| Andrew Makrides Director | Sep 19, 2014 | Tax withholding | −12,241 | $4.35 | $53.25K | 611,972 |
| J. Robert Saron President, Director | Sep 19, 2014 | Option exercise | +12,500 | $2.13 | $26.63K | 399,819 |
| J. Robert Saron President, Director | Sep 19, 2014 | Tax withholding | +6,121 | $4.35 | $26.63K | 393,698 |
| George W. Kromer Director | Oct 1, 2013 | Gift | −4,000 | $2.91 | $11.64K | 247,508 |
| George W. Kromer Director | Dec 5, 2012 | Gift | −5,000 | $2.65 | $13.25K | 251,508 |
| George W. Kromer Director | Sep 6, 2012 | Gift | −5,000 | $2.66 | $13.30K | 256,508 |
| Gregory Alan Konesky Director | Dec 23, 2011 | Sale | −750 | $2.40 | $1.80K | 1,750 |
| Universal Growth Investment Trust RENN Director | Aug 25, 2011 | Buy | +7,100 | $2.70 | $19.17K | 1,247,800 |
| Universal Growth Investment Trust RENN Director | Aug 24, 2011 | Buy | +14,100 | $2.66 | $37.51K | 1,240,770 |
| Universal Growth Investment Trust RENN Director | Aug 23, 2011 | Buy | +11,600 | $2.55 | $29.58K | 1,226,600 |
| Universal Growth Investment Trust RENN 10% owner | Aug 9, 2011 | Buy | +100,000 | $2.45 | $245.00K | 1,215,000 |
| Universal Growth Investment Trust RENN 10% owner | Aug 9, 2011 | Buy | +15,000 | $2.09 | $31.35K | 1,115,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Todd Hornsby Officer | Jun 21, 2023 | 15,000 | $105.30K | Jun 21, 2023 | Stock Option Exercise |